Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Impact Healthcare (IHR)

  Print      Mail a friend

Thursday 11 January, 2018

Impact Healthcare


RNS Number : 5529B
Impact Healthcare REIT PLC
11 January 2018

11th January 2018

Impact Healthcare REIT plc

(the "Company" and with its subsidiaries, the "Group")


The Board of Directors of Impact Healthcare REIT plc (ticker: IHR) is pleased to announce that the Group has exchanged contracts to acquire in a sale and leaseback transaction a portfolio of three purpose-built care homes in the North-East of England (the "Portfolio") for a total consideration of £17 million (including costs). Completion is conditional on, among other things, regulatory approvals, and is expected to take place before the end of the first quarter of 2018.


The Portfolio is being acquired from the Prestige Care Group ("Prestige"), a developer and operator of care homes with over 20 years' experience in the care industry. Prestige will continue to operate the homes as the Group's tenant following completion. The Group will enter into new full repairing and insuring leases with Prestige in respect of each of the properties for an initial 20 years, with an option for the Group to extend to 30 years. Prestige has committed to a minimum annual expenditure on maintenance.


The rents receivable under the leases are subject to annual, upward only rent reviews, increasing in line with Retail Prices Index, with a floor of 2% p.a. and a cap of 4% p.a.


The net initial yield and level of rent cover are in line with the terms on which the Group acquired its seed portfolio shortly following the Company's initial public offering.


Each of the care homes in the portfolio was purpose-built by Prestige and the portfolio comprises a total of 234 high-quality care beds and an additional 40 beds which present an asset management opportunity. The care provided by Prestige at each of the three homes is currently rated "Good" by the Care Quality Commission.


The Portfolio consists of the following properties:

·     Sand Banks in Redcar, the home town of Prestige's founder, was built in 2015 and opened at the end of that year. It was built to a high standard with 77 large bedrooms set in well-landscaped grounds. Since opening it has established a track record of delivering good quality care while also delivering on its operating and financial targets.

·     Roseville is in the heart of Ingleby Barwick, one of the largest private residential housing estates in the country.  It was built to the same standards as Sand Banks with the first phase delivered in 2010 and an extension in 2012 and today the home offers a total of 103 bedrooms across the two units. Both homes have good provision of well-appointed common areas for activities and recreation. 

·     Parkville, in central Middlesbrough consists of two units on one site both of which are two-storey buildings offering a total of 94 beds. The Group will acquire the freehold of both units on completion. The home was built by Prestige in 2005 and was originally let to Southern Cross. However, after Southern Cross ran into difficulties, Prestige took back control of the home in 2013. Subsequently:

The 54-bed unit was refurbished in 2013 and has been a popular and well occupied care home since then.

The 40-bed unit was closed awaiting further investment. The Group and Prestige have agreed that Prestige will reinvest sufficient capex to bring this home up to the same standards internally as the newer homes in the Portfolio. Once this unit has reopened and is operating successfully, the Group will make a further, performance-based payment to Prestige. The rent due from Parkville will increase in line with the amount of this deferred payment.


The Portfolio is one of the target portfolios identified by the Group at the time of the fundraise completed in November 2017. The Group has also agreed exclusivity on three further acquisitions, with three different tenants, and continues to evaluate a strong attractive pipeline of potential investment opportunities.


Rupert Barclay, Chairman of Impact Healthcare REIT plc, commented:

"We are pleased to announce the first of a number of potential acquisitions that the Group expects to make in 2018.  Prestige brings high quality purpose-built care homes to the Group at an attractive price, which will increase our total number of beds by 11%. Prestige is a new tenant for the Group and one with an enviable reputation for being committed to providing high quality, affordable care.


The Portfolio has the potential to deliver upside through active asset management at Parkville. We are considering other projects  with Prestige, with whom we look forward to having a long and successful partnership."



Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Newgate Communications



Winterflood Securities Limited

Joe Winkley

Neil Langford

Tel: 020 3100 0000



Newgate Communications (PR Adviser)

James Benjamin

Anna Geffert

Lydia Thompson

Tel: 020 7680 6550

Email: [email protected]


The Company's LEI is 213800AX3FHPMJL4IJ53.


Further information on Impact Healthcare REIT is available at



The Group is a real estate investment trust ("REIT") which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of healthcare real estate opportunities, in particular residential care homes. The Group's investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.

The Group is targeting an aggregate dividend of 6.0 pence per share for the first 12 months from Admission which equates to a yield of 6 per cent. per annum on the IPO Issue Price, payable in quarterly instalments(1).

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, Specialist Fund Segment, on 7 March 2017.

(1)   This is a target only and not a profit forecast and there can be no assurance that it will be met and it should not be taken as an indication of the Group's actual or expected future results.

This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t